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ABSTRACT 
Aims: The purpose of this study was to evaluate whether the carotid IMT identified by using 
automated software is associated with HbA1c in Japanese Coronary Artery Disease Patients. 
 
Methods: 370 consecutive patients (males 218; median age 69 years ± 11) who underwent 
carotid-US and first coronary angiography were prospectively analyzed. After 
ultrasonographic examinations were performed, the plaque score (PS) was calculated and 
automated IMT analysis was obtained with a dedicated algorithm. Pearson correlation 
analysis was performed to calculate the association between automated IMT, PS and HbA1c. 
 
Results: The mean value of cIMT was 1.00±0.47 mm for the right carotid and 1.04±0.49 mm 
for the left carotid; the average bilateral value was 1.02±0.43 mm. No significant differences 
of cIMT were detected between men and women. We found a direct correlation between the 
cIMT values and the levels of HbA1c (p=0.0007) whereas the plaque score did not correlate 
with the HbA1c values (p > 0.05) 
 
Conclusion: Results of our study confirm that the automated cIMT values and the levels of 
HbA1c in Japanese Coronary Artery Disease Patients are correlated whereas the plaque score 
does not show any statistically significant correlation.  
 
 
Keywords: ultrasonography, intima-media thickness, carotid, HbA1c, automated 
measurement. 
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Introduction 
Intima media thickness of the carotid arteries (cIMT) is a validated surrogate marker 
of early atherosclerosis and is associated with coronary atherosclerosis [1] and with the risk of 
future vascular events [2]. Because it can be measured relatively simply and noninvasively, it 
is well suited for use in large-scale population studies. Ultrasonic measurements correlate 
well with histology [3, 4] and increased IMT is associated with vascular risk factors [5]
 
and 
the presence of more advanced atherosclerosis [6], which includes coronary artery disease 
(CAD).  
In the past years, the cIMT was calculated by the sonographers that performed the 
examination by tracing a line between the two interfaces lumen\intima and media\adventia
 
[7]. In the last years, thanks to the rapidly growing of the hardware and algorithms analysis 
[8], it became possible to automatically calculate the cIMT [9-11] avoiding one of the most 
important limit of the manual analysis of the IMT: the poor inter\intra-observer agreement 
[12, 13].  
The important role of long-term hyperglycemia in the development of atherosclerosis 
is known and a correlation between HbA1c and cIMT was demonstrated especially in women 
[14] and in children [15, 16] affected by type 1 diabetes. The accurate monitoring in critical 
patients, such as the patients with type 2 diabetes, is crucial since persons with diabetes have 
2-6 folds higher cardiovascular risk than subjects without diabetes [17-19]. Recently, male 
gender was also associated to a more rapid increase of the cIMT even in Type 2 diabetes [20], 
thus further increasing the need for accurate measurement and monitoring. In a recent review, 
Kurukulasuriya and Sowers showed that the reduction of the glycated hemoglobin (HbA1c) is 
associated with a lower incidence of myocardial infarction, but they also evidenced that the 
management of the cardiovascular risk factors experienced by patients with type 2 diabetes 
required a multidisciplinary approach with implementation of strategies to also improve the 
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underlying cardiovascular risk factors [21]. It is, therefore, evident that accurate diagnostic 
and prognostic vascular tools are needed in association to the study and assessment of 
patients’ HbA1c levels. 
In this study, we aimed to evaluate whether the cIMT identified by using automated 
software called AtheroEdge, which can process a large set of ultrasound images 
automatically, was associated with HbA1c levels in a population affected by CAD. 
 
Material and Methods 
Patient population. Three-hundred-seventy consecutive Japanese patients (males 
218, females 152; median age 69 ± 11 years) admitted to Toho University Ohashi Medical 
Center from December 2008 to January 2011 who underwent carotid-US and first coronary 
angiography were prospectively analyzed. Coronary angiography was performed to evaluate 
ischemic heart disease or cardiomyopathy and as the preoperative investigation for ischemic 
heart, aortic disease, or valvular disease. Our study complied with the Declaration of Helsinki, 
and written informed consent was obtained from all patients. Part of our population was used 
in a recently published study [22]. 
 
Carotid ultrasonography. Ultrasonographic examinations were performed with a 
scanner (Aplio XV, Aplio XG, Xario, Toshiba, Inc., Tokyo, Japan) equipped with a 7.5-MHz 
linear array transducer. All scans were performed by the same experienced sonographer (R 
Fijisaki with 10 years of experience). Subjects were examined in the supine position with the 
head tilted backwards. After the carotid arteries were located by transverse scans, the probe 
was rotated 90° to obtain and acquire a longitudinal image of the anterior and posterior walls. 
The high-resolution images of the far wall were acquired according to recommendations of 
the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. 
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Moreover, the high-resolution images of the internal carotid arteries (ICA) and carotid bulbs 
(other than the CCA) were acquired in order to calculate the plaque score (PS). 
  The HbA1c was calculated as the National Glycohemoglobin Standardization 
Program (NGSP) equivalent value using the following formula: HbA1c (NGSP) (%) = 1.02 × 
HbA1c (Japan Diabetes Society) (%) + 0.25% [23]. 
 
Automated Far Wall LI/MA Delineation. The IMT measurement was completely 
automated. Our strategy was based on the following three basic steps: 
 Step-1: automated image cropping. 
 Step-2: automated carotid artery far wall recognition. 
 Step-3: automated LI/MA far wall tracings. 
For an automated method, we need a correct region of interest, which only consists of 
tissue region. Therefore, in Step-1, the goal is to automatically crop the region of interest 
(tissue region) in this ultrasound B-mode image. Since our images are in JPEG format, we 
adopt a gradient-based strategy, which removes all the image rows and columns that are black 
and do not contain intensity variations in ultrasound image. The detailed procedure was 
previously reported by Molinari et al. [24]. Once the grayscale region of interest image was 
obtained, Step-2 consists of an integrated procedure combining feature extraction and 
classification was used to automatically track the carotid artery [25, 26]. The hypothesis at the 
base of this procedure is that the far wall adventitia layer (ADF) is the brightest feature in the 
image [27]. Our procedure first identifies all the “seed points”. A seed point is a local 
intensity maximum with intensity value higher than that of the average surrounding pixels. 
Seed points are located on the bright features of the image. These seed points are connected to 
form line segments. Line segments for the cropped image of fig. 1.A are reported in fig. 1.B. 
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All the line segments are then connected and the one located on the brightest interface is 
considered as the far adventitia layer profile. The ADF profile for the image in fig. 1.A is 
depicted by fig. 1.C. 
Finally, once the ADF profile was traced, Step-3 consisted of automated LI/MA tracings. 
[26, 28]. We adapted three types of intensities in our approach at this point. Lumen region 
(cluster 1), the intima or media layer (cluster 2), or the adventitia layer (cluster 3). The pixels 
at the transitions of the clusters 1 and 2 form the LI boundary, whereas the pixels at the 
transition between the clusters 2 and 3 form the MA boundary. The final Delineation of the 
carotid artery of fig. 1.A is shown in fig. 2. 
 
Statistical analysis. Correlation plots were performed to assess the relationship 
between the cIMT values and Plaque Score versus the percent value of HbA1c. Correlation 
was numerically measured by using the Pearson rho coefficient along with its 95% confidence 
interval. The statistical existence of correlation between the variables was measured by the 
correlation level of significance (correlation was considered significant if the p value was 
lower than 0.05). The normality of each continuous variable group was tested using the 
Kolmogorov-Smirnov Z test.  
 
Results and Discussion 
AtheroEdge was able to detect the cIMT in all patients and its validation was yet published in 
previous manuscripts of our group (blinded for peer review). In details, the mean value of 
cIMT evaluated at level of CCA was 1.00±0.47 mm for the right carotid and 1.04±0.49 mm 
for the left carotid; the average bilateral value was 1.02±0.43 mm. No significant differences 
were detected between men and women cIMT. The cIMT values manually measured by an 
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expert Reader were 0.94±0.29 mm for the right and 1.03±0.41 mm for the left carotid side. 
Therefore, the measurement bias was equal to 0.06±0.41 mm and 0.01±0.42 for the right and 
left side, respectively.  
Table 1 summarizes the demographics, physical and clinical characteristics of the studied 
subjects. In our population we had 218 subjects (prevalence of 43.5%) with evidence of 
coronary artery disease and the SYNTAX score (SXscore) was 8.8 ± 15.0 (Normality rejected 
with a p value of 0.001). The PlaqueScore (PS) was 7.0 ± 5.3 (Normality rejected with a p 
value of 0.001) whereas the mean Auto-IMT (obtained by averaging the left and right side) 
was 0.85 ± 0.25 mm (Normality rejected with a p value of 0.001).  
We found a direct correlation between the cIMT values and the levels of HbA1c (rho = 
0.1761; p=0.0007; Figure 3A); on the other hand, the plaque score did not correlate with the 
HbA1c values (rho = 0.0798; p=0.1340; Figure 3B). We also did not find a significant 
correlation between te cIMT and the glucose (rho = 0.060; p=0.266), LDL (rho = -0.006; 
p=0.943), and HDL levels (rho = -0.064; p=0.390). 
Carotid IMT is considered a reliable measure of generalized atherosclerosis. Previous 
investigation have demonstrated that a thickened cIMT is correlated with an increased risk of 
stroke and myocardial infarction [29] and it is predictive of future events of coronary heart 
diseases in subjects with type 2 diabetes [30, 31]. In this study our purpose was to evaluate 
whether the cIMT, identified by using AtheroEdge automated software, is associated with 
HbA1c in Coronary Artery Disease Patients and we found a strong association between 
cIMT, measured by the means of AtheroEdge, and HbA1c in the whole study population (p = 
0.0007) . 
Previous investigations have demonstrated that there is an association between the diabetes 
and the IMT [32-34], but the association, and its strength, between IMT and the diabetes is 
still debated [35]. In 2010, Einarson et al. revised 172 papers and found a weak but 
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statistically significant correlation between glucose levels and coronary IMT [36]. One of the 
limitations in the previous studies that explored the association between the atherosclerosis or 
the arteries’ IMT and diabetes was the technology used for the IMT quantification. In 
particular it is well known that the IMT can suffer of multiple bias and in particular the poor 
inter-observer agreement [37]. Lorentz et al., in a meta-analysis of 8 studies which represent 
37197 subjects, highlight multiple sources of heterogeneity between the studies based on the 
cIMT assessment: these include the details of the ultrasound protocol, namely the precise 
definitions of the carotid segments investigated, the use of mean or maximal IMT, the 
measurement of near and far wall or only far wall IMT, and whether IMT was measured only 
on 1 side or on both sides [2].
 
The technique we used allows to standardize the measurement 
process and then to improve the reproducibility of the results. 
Our study results are concordant with those found by Bobbert et al. [38], but one of the 
points of major originality of our manuscript is the use of a completely automated cIMT 
measurement using AtheroEdge. Our methodology is validated in previous publication that 
demonstrated an excellent reproducibility of the software. Therefore the association we found 
between the cIMT and HbA1c can be considered further strengthened by the methodology for 
the IMT quantification   
We did not find any statistically significant correlation between the plaques score and the 
HbA1c (rho value = 0.0789); this data are concordant with the literature. In the recently 
published study by Herder et al. [39] in a population of 2741 patients, it was found that the 
diabetes was predictor for IMT and IMT progression, whereas the total cholesterol, smoking, 
and systolic blood pressure were stronger long-term predictors of carotid plaque area and 
carotid plaque area progression than for IMT and IMT progression. 
Resubmission to be Diabetes Research and Clinical Practice – March 2013 
9/14 
In this study there are some limitations: the first one is that we did not consider in our 
analysis the diabetes duration. This fact may represent a bias because some authors consider 
that the diabetes duration is an important factor impacting on carotid thickening [40-42].  
In conclusion, results of our study confirm that the automated cIMT values and the levels 
of HbA1c are correlated whereas the plaque score does not show any statistically significant 
correlation. 
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A) Original and cropped B-Mode image (right carotid artery in the common tract). B) Line 
segments automatically traced by AtheroEdge. C) Automated tracing of the ADF. 
 
Figure 2 
Automated AtheroEdge LI/MA tracings of the far distal wall. 
 
Figure 3 
Correlation plots between the AtheroEdge CIMT values (panel A) and Plaque Score (panel 
B) versus the percent value of HbA1c. 
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Table 1. Demographics and clinical characteristics of the patients. The rightmost column 
reports the p value for the normality test (Kolmogorov-Smirnov). 
Table 1 
Parameter Value K-S test 
Male (%) 62.3% NC 
Age 69 ± 11 0.018 
Diabetes mellitus 17.4% NC 
Hypertension 56.3% NC 
Albumine 4.14 ± 0.37  0.001* 
Creatinine 1.58 ± 2.09 0.001* 
Haemoglobin A1c 
5.6 ± 1.0 % 
(37 ± 13 mmol/mol) 
0.001* 
Glucose (mg/dL) 109 ± 31 0.001* 
Total cholesterol (mg/dL) 182 ± 38 0.604 
Low density lipoprotein cholesterol (mg/dL) 105 ± 34 0.556 
High density lipoprotein cholesterol (mg/dL) 53 ± 15 0.029 
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